FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $2.5B
This Quarter Return
-9.64%
1 Year Return
+52.94%
3 Year Return
+530.54%
5 Year Return
10 Year Return
AUM
$1.17B
AUM Growth
Cap. Flow
+$1.17B
Cap. Flow %
100%
Top 10 Hldgs %
60.23%
Holding
42
New
42
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 98.72%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PRDS
26
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$15M 1.28%
+2,081,007
New +$15M
FLACU
27
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$15M 1.28%
+1,501,000
New +$15M
NTLA icon
28
Intellia Therapeutics
NTLA
$1.26B
$14.8M 1.26%
+203,684
New +$14.8M
STRO icon
29
Sutro Biopharma
STRO
$85.6M
$14.6M 1.24%
+1,776,479
New +$14.6M
TYRA icon
30
Tyra Biosciences
TYRA
$657M
$14.2M 1.21%
+1,327,665
New +$14.2M
REPL icon
31
Replimune Group
REPL
$460M
$12.2M 1.04%
+716,762
New +$12.2M
GRCL
32
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$8.03M 0.68%
+3,445,973
New +$8.03M
ACRS icon
33
Aclaris Therapeutics
ACRS
$223M
$7.04M 0.6%
+408,329
New +$7.04M
AVDL
34
Avadel Pharmaceuticals
AVDL
$1.42B
$6.5M 0.55%
+951,814
New +$6.5M
MTEM
35
DELISTED
Molecular Templates, Inc.
MTEM
$4.74M 0.4%
+1,374,047
New +$4.74M
EPIX icon
36
ESSA Pharma
EPIX
$11.2M
$4.28M 0.36%
+692,910
New +$4.28M
APTX
37
DELISTED
Aptinyx Inc. Common Stock
APTX
$4.28M 0.36%
+1,883,244
New +$4.28M
IMVT icon
38
Immunovant
IMVT
$2.91B
$3.23M 0.28%
+585,759
New +$3.23M
SRRK icon
39
Scholar Rock
SRRK
$3.3B
$2.01M 0.17%
+156,000
New +$2.01M
CERE
40
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$1.96M 0.17%
+55,835
New +$1.96M
EPZM
41
DELISTED
Epizyme, Inc
EPZM
$850K 0.07%
+739,369
New +$850K
NBRV
42
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$179K 0.02%
+425,650
New +$179K